XML 58 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business segment information
 3 Months Ended
Mar. 31, 2013
Segment Reporting [Abstract]  
Business segment information

14. Business segment information

The Company’s segment information (as provided below) has been prepared based on the Company’s two global business units (“GBU”) reporting segments, Spine and Orthopedics. The accounting policies of the segments are the same as those described in the business segment information found in Note 12 to the Consolidated Financial Statements included in our Annual Report on Form 10-K, as amended, for the year ended December 31, 2012.

The table below presents external net sales by GBU reporting segment. Net sales include product sales and marketing service fees. Marketing service fees, which are recorded on a net basis, are comprised of sales of Trinity Evolution ® in spine and orthopedic applications.

 

     External Net Sales by GBU  
     Three Months Ended March 31,  

(US$ in thousands)

    2013      2012      Reported
Decline		     Constant
Currency
Decline		  

Spine

           

Spine Repair Implants and Regenerative Biologics

    $ 34,297       $ 35,757         (4 )%     (4 )% 

Spine Regenerative Stimulation

      32,029         39,271         (18 )%     (18 )%
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Spine

      66,326         75,028         (12 )%     (12 )%

Orthopedics

      33,928         41,014         (17 )%     (16 )%
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Net Sales

    $ 100,254       $ 116,042         (14 )%     (13 )%
  

 

 

     

 

 

     

 

 

    

 

 

  

The table below presents operating income (loss) by GBU reporting segment:

 

Operating Income (Loss) by GBU    Three Months Ended
March 31,		  

(US$ in thousands)

    2013     2012  

Spine

    $ 11,845      $ 21,566   

Orthopedics

      958        4,979   

Corporate (1)

      (8,779 )      (4,114 ) 
  

 

 

    

 

 

  

Total

    $ 4,024      $ 22,431   
  

 

 

    

 

 

  

 

(1) For the three months ended March 31, 2013, the operating loss for Corporate included $3.6 million of management succession charges.